Lill-Tove Rasmussen Busund
Stillingsbeskrivelse
Leder Translasjonell Kreftforskning IMB
Eiliv Lund,
Lill-Tove Rasmussen Busund,
Lars Holden
:
Curvilinear incidence models for parity in the entire fertility range for cancers of the breast, ovary, and endometrium: A follow-up of the Norwegian 1960 Census
International Journal of Cancer 2025 DOI
Masoud Tafavvoghi,
Lars Ailo Aslaksen Bongo,
Nikita Shvetsov,
Lill-Tove Rasmussen Busund,
Kajsa Møllersen
:
Publicly available datasets of breast histopathology H&E whole-slide images: A scoping review
Dagny Førde,
Thomas Karsten Kilvær,
Mona Irene Pedersen,
Egil Støre Blix,
Ilona Halva Urbarova,
Erna-Elise Paulsen
m.fl.:
High density of TCF1+ stem-like tumor-infiltrating lymphocytes is associated with favorable disease-specific survival in NSCLC
Eline Sol Garthsdatter Tylden,
Andrè Berli Delgado,
Marko Lukic,
Line Moi,
Lill-Tove Rasmussen Busund,
Mona Irene Pedersen
m.fl.:
Roles of miR-20a-5p in breast cancer based on the clinical and multi-omic (CAMO) cohort and in vitro studies
Masoud Tafavvoghi,
Anders Sildnes,
Mehrdad Rakaee,
Nikita Shvetsov,
Lars Ailo Aslaksen Bongo,
Lill-Tove Rasmussen Busund
m.fl.:
Deep learning-based classification of breast cancer molecular subtypes from H&E whole-slide images
Mehrdad Rakaee,
Masoud Tafavvoghi,
Biagio Ricciuti,
Joao V Alessi,
Alessio Cortellini,
Fabrizio Citarella
m.fl.:
Deep Learning Model for Predicting Immunotherapy Response in Advanced Non-Small Cell Lung Cancer
Eiliv Lund,
Lill-Tove Rasmussen Busund,
Lars Holden
:
The curvilinear relationships between grand parity and incidence of hormone-dependent cancers; follow-up of postmenopausal women in the Norwegian 1960 Census
Erna-Elise Paulsen,
Sigve Andersen,
Mehrdad Rakaee,
Mona Irene Pedersen,
Ana Paola Lombardi,
Mette Pøhl
m.fl.:
Impact of microvessel patterns and immune status in NSCLC: a non-angiogenic vasculature is an independent negative prognostic factor in lung adenocarcinoma
Mehrdad Rakaee,
Sigve Andersen,
K. Giannikou,
Erna-Elise Paulsen,
Thomas Karsten Kilvær,
Lill-Tove Rasmussen Busund
m.fl.:
Machine learning-based immune phenotypes correlate with STK11/KEAP1 co-mutations and prognosis in resectable NSCLC: a sub-study of the TNM-I trial
Hallgeir Selven,
Lill-Tove Rasmussen Busund,
Sigve Andersen,
Mona Irene Pedersen,
Ana Paola Lombardi,
Thomas Karsten Kilvær
:
High Expression of IRS-1, RUNX3 and SMAD4 Are Positive Prognostic Factors in Stage I–III Colon Cancer
André Berli Delgado,
Eline Sol Garthsdatter Tylden,
Marko Lukic,
Line Haugan Moi,
Lill-Tove Rasmussen Busund,
Eiliv Lund
m.fl.:
Cohort profile: The Clinical and Multi-omic (CAMO) cohort, part of the Norwegian Women and Cancer (NOWAC) study
Nikita Shvetsov,
Morten Grønnesby,
Edvard Pedersen,
Kajsa Møllersen,
Lill-Tove Rasmussen Busund,
Ruth Schwienbacher
m.fl.:
A Pragmatic Machine Learning Approach to Quantify Tumor-Infiltrating Lymphocytes in Whole Slide Images
Marta Tellez Gabriel,
Xavier Tekpli,
Trine M. Reine,
Beate Hegge,
Stephanie Rose Nielsen,
Meng Chen
m.fl.:
Serglycin is Involved in TGF-β induced epithelial-mesenchymal transition and is highly expressed by immune cells in breast cancer tissue
Hallgeir Selven,
Sigve Andersen,
Mona Irene Pedersen,
Ana Paola Lombardi,
Lill-Tove Rasmussen Busund,
Thomas Karsten Kilvær
:
High expression of miR-17-5p and miR-20a-5p predicts favorable disease-specific survival in stage I-III colon cancer
Maria Jenvin Støen,
Sigve Andersen,
Mehrdad Rakaee,
Mona I. Pedersen,
Lise Martine Ingebriktsen,
Tom Dønnem
m.fl.:
Overexpression of mir-20a-5p in tumor epithelium is an independent negative prognostic indicator in prostate cancer—a multi-institutional study
Mehrdad Rakaee,
Thomas Karsten Kilvær,
Simin Jamaly,
Thomas Berg,
Erna-Elise Paulsen,
Marte Berglund
m.fl.:
Tertiary lymphoid structure score: a promising approach to refine the TNM staging in resected non-small cell lung cancer
British Journal of Cancer 2021 DOI
Maria Jenvin Støen,
Sigve Andersen,
Mehrdad Rakaee,
Mona Irene Pedersen,
Lise Martine Ingebriktsen,
Roy M. Bremnes
m.fl.:
High expression of miR-17-5p in tumor epithelium is a predictor for poor prognosis for prostate cancer patients
Hallgeir Selven,
Lill-Tove Rasmussen Busund,
Sigve Andersen,
Roy M. Bremnes,
Thomas Karsten Kilvær
:
High expression of microRNA‑126 relates to favorable prognosis for colon cancer patients
Mie Jareid,
Igor Snapkov,
Marit Holden,
Lill-Tove Rasmussen Busund,
Eiliv Lund,
Therese Haugdahl Nøst
:
The blood transcriptome prior to ovarian cancer diagnosis: A case-control study in the NOWAC postgenome cohort
Karina Standahl Olsen,
Marit Holden,
Jean-Christophe Thalabard,
Lill-Tove Rasmussen Busund,
Eiliv Lund,
Lars Holden
:
Global blood gene expression profiles following a breast cancer diagnosis—Clinical follow-up in the NOWAC post-genome cohort
Eiliv Lund,
Marit Holden,
Jean-Christophe Thalabard,
Lill-Tove Rasmussen Busund,
Igor Snapkov,
Lars Holden
:
Signals of Death - Post-Diagnostic Single Gene Expression Trajectories in Breast Cancer - A Proof of Concept
Lill-Tove Rasmussen Busund
:
Hypothesis of Carcinogenesis - The Atavistic Theory
Universitetsforlaget 2020 DOI
Thomas Karsten Kilvær,
Erna-Elise Paulsen,
Sigve Andersen,
Mehrdad Rakaee,
Roy M. Bremnes,
Lill-Tove Rasmussen Busund
m.fl.:
Digitally quantified CD8+ cells: the best candidate marker for an immune cell score in non-small cell lung cancer?
Elin Richardsen,
Sigve Andersen,
Christian Melbø-Jørgensen,
Mehrdad Rakaee,
Nora Ness,
Samer Al-Saad
m.fl.:
MicroRNA 141 is associated to outcome and aggressive tumor characteristics in prostate cancer
Line Moi,
Tonje Braaten,
Khalid Al-Shibli,
Eiliv Lund,
Lill-Tove Rasmussen Busund
:
Differential expression of the miR-17-92 cluster and miR-17 family in breast cancer according to tumor type; results from the Norwegian Women and Cancer (NOWAC) study
Mehrdad Rakaee,
Lill-Tove Busund,
Simin Jamaly,
Erna-Elise Paulsen,
Elin Richardsen,
Sigve Andersen
m.fl.:
Prognostic Value of Macrophage Phenotypes in Resectable Non–Small Cell Lung Cancer Assessed by Multiplex Immunohistochemistry
Thomas Karsten Kilvær,
Mehrdad Rakaee,
Turid Hellevik,
Jørg Vik,
Luigi de Petris,
Tom Dønnem
m.fl.:
Differential prognostic impact of platelet-derived growth factor receptor Expression in NSCLC
Elin Richardsen,
Sigve Andersen,
Samer Al-Saad,
Mehrdad Rakaee,
Yngve Nordby,
Mona Irene Pedersen
m.fl.:
Low expression of miR-424-3p is highly correlated with clinical failure in prostate cancer
Sigurd Hald,
Mehrdad Rakaee,
Inigo Zubiavrre Martinez,
Elin Richardsen,
Samer Al-Saad,
Erna Elise Paulsen
m.fl.:
LAG-3 in Non-Small-cell Lung Cancer: Expression in Primary Tumors and Metastatic Lymph Nodes Is Associated With Improved Survival
Clinical Lung Cancer 2018 DOI
Kaja Konstanse Skjefstad,
Charles Johannessen,
Thea K.W. Grindstad,
Thomas Karsten Kilvær,
Erna Elise Paulsen,
Mona Irene Pedersen
m.fl.:
A gender specific improved survival related to stromal miR-143 and miR-145 expression in non-small cell lung cancer
Mehrdad Rakaee,
Thomas Karsten Kilvær,
Stig Manfred Dalen,
Elin Richardsen,
Erna Elise Paulsen,
Sigurd Hald
m.fl.:
Evaluation of tumor-infiltrating lymphocytes using routine H&E slides predicts patient survival in resected non-small cell lung cancer
Human Pathology 2018 DOI
Thea K.W. Grindstad,
Elin Richardsen,
Sigve Andersen,
Kaja Konstanse Skjefstad,
Mehrdad Rakaee,
Tom Dønnem
m.fl.:
Progesterone receptors in prostate cancer: Progesterone receptor B is the isoform associated with disease progression
Eiliv Lund,
Lill-Tove Busund,
Jean-Christophe Thalabard
:
Rethinking the carcinogenesis of breast cancer: The theory of breast cancer as a child deficiency disease or a pseudo semi-allograft
Yury Kiselev,
Sigve Andersen,
Charles Johannessen,
Bjørn Fjukstad,
Karina Standahl Olsen,
Helge Stenvold
m.fl.:
Transcription factor PAX6 as a novel prognostic factor and putative tumour suppressor in non-small cell lung cancer
Thomas Karsten Kilvær,
Mehrdad Rakaee,
Turid Hellevik,
Arne Östman,
Carina Strell,
Roy M. Bremnes
m.fl.:
Tissue analyses reveal a potential immune-adjuvant function of FAP-1 positive fibroblasts in non-small cell lung cancer
Yngve Nordby,
Elin Richardsen,
Nora Ness,
Tom Dønnem,
Hitendra R.H. Patel,
Lill-Tove Busund
m.fl.:
High miR-205 expression in normal epithelium is associated with biochemical failure - An argument for epithelial crosstalk in prostate cancer?
Elin Richardsen,
Sigve Andersen,
Samer Al-Saad,
Mehrdad Rakaee,
Yngve Nordby,
Mona Irene Pedersen
m.fl.:
Evaluation of the proliferation marker Ki-67 in a large prostatectomy cohort
Yngve Nordby,
Elin Richardsen,
Mehrdad Rakaee,
Nora Ness,
Tom Dønnem,
Hitendra R.H. Patel
m.fl.:
High expression of PDGFR-β in prostate cancer stroma is independently associated with clinical and biochemical prostate cancer recurrence
Samer Al-Saad,
Elin Richardsen,
Thomas Karsten Kilvær,
Tom Dønnem,
Sigve Andersen,
Mehrdad Rakaee
m.fl.:
The impact of MET, IGF-1, IGF1R expression and EGFR mutations on survival of patients with non-small-cell lung cancer
Erna-Elise Paulsen,
Thomas Karsten Kilvær,
Mehrdad Rakaee,
Elin Richardsen,
Sigurd Hald,
Sigve Andersen
m.fl.:
CTLA-4 expression in the non-small cell lung cancer patient tumor microenvironment: diverging prognostic impact in primary tumors and lymph node metastases
Sigve Andersen,
Elin Richardsen,
Mehrdad Rakaee,
Helena Bertilsson,
Roy M. Bremnes,
Magne Børset
m.fl.:
Expression of phosphatase of regenerating liver (PRL)-3, is independently associated with biochemical failure, clinical failure and death in prostate cancer
Eric J. Duell,
Leila Lujan-Barroso,
Núria Sala,
Samantha Deitz McElyea,
Kim Overvad,
Anne Tjønneland
m.fl.:
Plasma microRNAs as biomarkers of pancreatic cancer risk in a prospective cohort study
Åslaug Helland,
Odd Terje Brustugun,
Sigve Nakken,
Ann Rita Halvorsen,
Tom Dønnem,
Roy M. Bremnes
m.fl.:
High number of kinome-mutations in non-small cell lung cancer is associated with reduced immune response and poor relapse-free survival
Nora Ness,
Sigve Andersen,
Mehrdad Rakaee,
Cecilie Nordbakken,
Andrey Yurjevich Valkov,
Erna-Elise Paulsen
m.fl.:
The prognostic role of immune checkpoint markers programmed cell death protein 1 (PD-1) and programmed death ligand 1 (PD-L1) in a large, multicenter prostate cancer cohort
Elio Adib,
falah jabar,
Masoud Tafavvoghi,
Amin Nassar,
Lill-Tove Rasmussen Busund,
Tom Dønnem
m.fl.:
Artificial Intelligence-powered analysis of the tumor immune microenvironment in primary and metastatic colorectal cancer
2024
falah jabar,
Sigve Andersen,
Erna-Elise Paulsen,
Masoud Tafavvoghi,
Elin Helmine Richardsen,
Sissel Gyrid Freim Wahl
m.fl.:
Integrating Artificial intelligence (AI)-based lymphocytic infiltration assessment in early-stage NSCLC: A sub-study of the TNM-I trial
2024
Mehrdad Rakaee,
Masoud Tafavvoghi,
Elio Adib,
Biagio Ricciuti,
Joao Alessi,
Alessio Cortellini
m.fl.:
Artificial intelligence algorithm developed to predict immune checkpoint inhibitors efficacy in non–small-cell lung cancer
2023
Scheiner Bernhard,
Alessio Antonio,
Kim Gwangil,
D. Goldin Robert,
A.M. Fulgenzi Claudia,
Balcar Lorenz
m.fl.:
MACHINE LEARNING-BASED ASSESSMENT OF TUMOUR- INFILTRATING LYMPHOCYTES PREDICTS OUTCOMES IN PATIENTS WITH HEPATOCELLULAR CARCINOMA UNDERGOING ATEZOLIZUMAB AND BEVACIZUMAB TREATMENT
2023
Mehrdad Rakaee,
Elio Adib,
Biagio Ricciuti,
Lynette M. Sholl,
Joao V.Alessi,
Alessio Cortellini
m.fl.:
Digital quantification of lymphocytic infiltration on routine H&E images and immunotherapy response in non-small cell lung cancer
2022
Kaja Konstanse Skjefstad,
Thea K.W. Grindstad,
Mehrdad Rakaee,
Elin Richardsen,
Tom Dønnem,
Thomas Karsten Kilvær
m.fl.:
Corrigendum to "Prognostic relevance of estrogen receptor α, β and aromatase expression in non-small cell lung cancer" [Steroids 113 (2016) 5-13]
Steroids 2018 DOI
De 50 siste resultatene fra Cristin vises på siden. Se alle arbeider i Cristin her →
Forskningsinteresser
Biomarkører i kreftsvulster og blod som kan gi informasjon om framtidig kreftsykdom, hvilken type kreftsykdom, prognose av kreftsykdom og hvilken behandling som kan gi effekt.
Undervisning
Leder Delemne 2.4 Bevegelse i Profesjonsstudiet Medisin
Medlem i forskningsgruppe
Medlem i prosjekt
Vedlegg:
- CV LTRB 2024 (pdf)